Nutex Health Inc. $NUTX Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. reduced its position in Nutex Health Inc. (NASDAQ:NUTX) by 13.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 28,676 shares of the company’s stock after selling 4,613 shares during the quarter. Pacer Advisors Inc. owned about 0.42% of Nutex Health worth $2,725,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bank of America Corp DE grew its position in Nutex Health by 52.3% during the first quarter. Bank of America Corp DE now owns 9,027 shares of the company’s stock valued at $858,000 after acquiring an additional 3,101 shares during the period. Smith Group Asset Management LLC acquired a new stake in Nutex Health during the first quarter worth about $1,244,000. EverSource Wealth Advisors LLC purchased a new position in shares of Nutex Health in the 1st quarter worth about $83,000. Empowered Funds LLC purchased a new position in shares of Nutex Health in the 1st quarter worth about $3,084,000. Finally, Quantinno Capital Management LP acquired a new position in shares of Nutex Health in the 1st quarter valued at about $843,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Analyst Ratings Changes

NUTX has been the subject of a number of research reports. Zacks Research upgraded Nutex Health to a “hold” rating in a report on Monday, June 29th. B. Riley Financial began coverage on shares of Nutex Health in a report on Friday, June 26th. They issued a “buy” rating and a $290.00 price target on the stock. Wall Street Zen cut shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 20th. Lake Street Capital assumed coverage on shares of Nutex Health in a research note on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price objective for the company. Finally, Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $243.33.

Nutex Health Price Performance

Shares of NASDAQ NUTX opened at $162.07 on Friday. Nutex Health Inc. has a 1-year low of $77.21 and a 1-year high of $204.00. The business has a 50-day moving average of $157.23 and a 200-day moving average of $129.20. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. The company has a market capitalization of $1.12 billion, a price-to-earnings ratio of 6.36 and a beta of 0.24.

Nutex Health Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.